Evaluation of the Clinician Collaboration ACP Model Utilizing the Serious Illness Conversation Guide (SICG) in Outpatient Oncology Clinic

Evaluation of the Clinician Collaboration ACP Model Utilizing the Serious Illness Conversation Guide (SICG) in Outpatient Oncology Clinic - Evaluation of the ACP model in Outpatient Oncology Clinic

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038522

Enrollment

Registered

2020-02-01

Start date

2020-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer

Interventions

Serious Illness Conversation Program Standard Palliative Care and introducing a ACP brochure issued by the Ministry of Health, Labor and Welfare

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Included when all of the following are met. 1) Patients with a diagnosis of untreatable, metastatic, or recurrent gastrointestinal cancer. 2) Patients with a histopathological diagnosis of gastric, esophageal, biliary, pancreatic, or colorectal cancer (regardless of histological type). 3) Patients who are within 6 weeks (42 days) of initiating palliative primary chemotherapy at Kyoto University Hospital and are able to visit the outpatient clinic. 4) Patients who have received an explanation of the disease diagnosis and palliative treatment. 5) Patients who are at least 20 years of age at the time consent is obtained. 6) Patients who are able to bring a family member to at least one ACP discussion. 7) Patients with an ECOG Performance Status (PS) of 0 to 2. 8) Patients whose written consent to participate in the study has been obtained.

Exclusion criteria

Exclusion criteria: Excluded when any of the following items apply. 1) Patients with the Distress and Impediment Thermometer (DIT) test score of 4 or more for distress and a score of 3 or more for impediment. 2) Patients who have had an ACP discussion prior to participation in this study, covering the full range of medical condition awareness, prognostic information sharing, values identification, and discussion of desired medical care and care. 3) Patients with higher brain dysfunction (apparent intellectual decline, attention deficits, and dysgraphia). 4) Patients who are unable to speak, read, or write in Japanese. 5) Patients who are judged by the attending physician to be unsuitable to be included in this study.

Design outcomes

Primary

Measure	Time frame
Patients' quality of life 24 weeks after starting ACP support	—

Countries

Japan

Contacts

Public ContactSayaka Takenouchi

Kyoto University Graduate School of Medicine Division of Human Health Sciences Department of Nursing Ethics

takenouchi.sayaka.6u@kyoto-u.ac.jp075-751-3958

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026